
Markets Rally, But Gufic BioSciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-30 15:33:48Despite a broader market rally, Gufic BioSciences Ltd has plunged to a fresh 52-week low of Rs 267.5 on 30 Mar 2026, extending its recent downtrend amid persistent financial headwinds and valuation concerns.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-03-29 10:10:37Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Gufic BioSciences Ltd Surges 7.25% to Day's High of Rs 301 — Outperforms Sector by 4.73 Percentage Points
2026-03-25 12:45:49The Sensex climbed 2.28% on 25 Mar 2026, yet Gufic BioSciences Ltd outpaced the broader market with a 7.25% gain, reaching an intraday high of Rs 301. This 4.73 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector's 2.21% advance highlights a distinctly stock-specific rally.
Read full news article
Gufic BioSciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals
2026-03-20 08:00:58Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with bearish trends intensifying across key indicators. Despite some bullish signals on shorter-term charts, the overall technical outlook has deteriorated, prompting a downgrade in its Mojo Grade to Strong Sell as of 17 Nov 2025.
Read full news article
Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-03-19 08:00:53Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent upgrade from a Sell to a Strong Sell rating by MarketsMOJO on 17 Nov 2025, the stock’s price action and technical indicators reveal a cautious outlook for investors navigating this evolving landscape.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-03-18 10:11:11Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-03-07 10:10:38Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 07 March 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read full news article
Gufic BioSciences Ltd Falls to 52-Week Low of Rs.268.65
2026-03-04 11:04:35Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.268.65 today, marking a significant point in its recent price trajectory. The stock has been on a declining path for the past three days, cumulatively losing 2.15% in returns, reflecting ongoing pressures within the company’s performance metrics and market valuation.
Read full news article
Gufic BioSciences Ltd Falls to 52-Week Low of Rs.268.65
2026-03-04 11:04:28Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.268.65 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.
Read full news articleGufic Biosciences Limited - Updates
03-Dec-2019 | Source : NSEGufic Biosciences Limited has informed the Exchange regarding 'grant of patent'.
Gufic Biosciences Limited - Board meeting Cancelled
15-Nov-2019 | Source : NSEGufic Biosciences Limited has informed the Exchange regarding Seeking extension of time for approval of Standalone Financial Results for the quarter and half year ended September 30, 2019.
Gufic Biosciences Limited - Trading Window
08-Nov-2019 | Source : NSEGufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Corporate Actions
No Upcoming Board Meetings
Gufic BioSciences Ltd has declared 10% dividend, ex-date: 22 Sep 25
No Splits history available
No Bonus history available
No Rights history available






